Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyMcLaren Health Plan genetic testing Prior Auth | O…
    Ask Trek AI about this page
    Currentmclaren health planPolicy N/A

    Genetic Testing Pre-authorization Requirements

    Customize your policy alerts

    Sign up for all mclaren health plan policy alerts

    Know when mclaren health plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document governs McLaren Health Plan's requirement that providers obtain pre-authorization for all genetic testing (including prenatal) and describes information the ordering practitioner must supply. It affects all McLaren Health Plan providers who order genetic tests.

    Policy Summary
    Payermclaren health plan
    PolicyGenetic Testing Pre-authorization Requirements
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionObtain pre-authorization and provide answers to 11 required questions with any genetic testing request.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    allpre-authorization required
    11required questions
    888-327-0671Medical Management

    Coverage Criteria

    Pre-authorization documentation questions

    Pre-authorization requests must include answers to ALL of the following questions to support medical necessity evaluation:

    Pre-authorization supporting questions: 1. Is this test appropriate for this patient? 2. Is the technical and clinical performance of the genetic test supported by peer-reviewed published research? 3. Does a definitive diagnosis remain uncertain despite a comprehensive workup that includes a detailed medical history, physical examination, pedigree analysis, genetic counseling, and completion of conventional diagnostic studies? 4. Will the test result impact or alter the medical management of the patient? 5. What are the limitations of the test? 6. Are there any major ethical, legal or safety issues of concern with the test? 7. Has the genetic test been cleared or approved by the U.S. Food and Drug Administration or will it be performed in a Clinical Laboratory Improvement Amendment-certified laboratory? 8. Is this a targeted test or a multi-gene panel? 9. Has a pathogenic variant been identified in an affected family member? 10. Is this the first time this test is being performed on this patient? 11. Has the genetic test been ordered by a medical professional such as a medical geneticist, developmental-behavioral pediatrician, condition-specific subspecialist, or neonatologist in the NICU, who has training in genetics and will ensure that face-to-face genetic counseling by appropriately trained professional(s) will accompany testing?

    Responses to all items are required information for the pre-authorization review.

    This policy does not list discrete item-by-item coverage criteria beyond the requirement that pre-authorization documentation include answers to the specified set of questions. Pre-authorization requests must include responses to the full set of 11 items used by McLaren Medical Management to evaluate medical necessity, including test appropriateness, evidence of technical and clinical performance, diagnostic context, impact on management, limitations, ethical/legal/safety issues, laboratory certification or FDA clearance, test type (targeted vs. multi-gene), family variant status, prior testing history, and confirmation that an appropriately trained ordering practitioner will ensure face-to-face genetic counseling accompanies testing.

    Policy Summary
    Payermclaren health plan
    PolicyGenetic Testing Pre-authorization Requirements
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionObtain pre-authorization and provide answers to 11 required questions with any genetic testing request.
    SourceLink
    On This Page
    Coverage CriteriaProvider Actions and RequirementsDefinitionsEligibility RequirementsBackgroundNot Covered

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    If the required information is not provided with the pre-authorization request or the responses do not satisfy McLaren Medical Management's medical necessity evaluation, the request may be denied. McLaren requires pre-authorization for all genetic testing (including prenatal testing), and absence of the answers to the 11 required questions or failure to demonstrate that testing meets the criteria referenced (e.g., relevance to management, validated test performance, appropriate laboratory certification, and provider qualifications) risks denial of coverage.

    Provider Actions and Requirements

    Prior Authorization

    Pre-authorization required for all genetic testing

    Pre-authorization is required for all genetic testing, including prenatal genetic testing. Referrals and pre-authorization requests are accepted from both PCPs and specialist providers.

    Note

    Provide complete justification using established criteria

    Ordering practitioners must use the 11-question framework and provide complete answers with the pre-authorization request; MHP uses external medical necessity criteria (e.g., Hayes, Apollo) together with the 11 questions to evaluate requests.

    • MHP utilizes Hayes and Apollo Medical Necessity Criteria and the '11 Questions to Ask When Making Genetic Testing Coverage Decisions' when evaluating requests.
    Documentation Required

    Information required with pre-authorization request (11 questions)

    The ordering practitioner must provide answers to all 11 specified questions listed in the policy as part of the pre-authorization submission to support medical necessity review.

    • 1. Is this test appropriate for this patient?
    • 2. Is the technical and clinical performance of the genetic test supported by peer-reviewed published research?
    • 3. Does a definitive diagnosis remain uncertain despite a comprehensive workup including history, exam, pedigree analysis, genetic counseling, and conventional studies?
    • 4. Will the test result impact or alter the medical management of the patient?
    • 5. What are the limitations of the test?
    • 6. Are there any major ethical, legal or safety issues of concern with the test?
    • 7. Has the genetic test been cleared or approved by the U.S. FDA or will it be performed in a CLIA-certified laboratory?
    • 8. Is this a targeted test or a multi-gene panel?
    • 9. Has a pathogenic variant been identified in an affected family member?
    • 10. Is this the first time this test is being performed on this patient?
    • 11. Has the genetic test been ordered by a medical professional with genetics training who will ensure face-to-face genetic counseling accompanies testing?
    Denial Risk

    Failure to obtain pre-authorization may result in denial

    Requests for genetic testing submitted without prior authorization may be denied because MHP requires pre-authorization for all genetic testing, including prenatal testing.

    Documentation Required

    Require face-to-face genetic counseling when ordered by genetics-trained providers

    When testing is ordered by a provider with genetics training, face-to-face genetic counseling by appropriately trained professionals must accompany the testing.

    • Examples of providers with genetics training include a medical geneticist, developmental-behavioral pediatrician, condition-specific subspecialist, or a neonatologist in the NICU.
    Note

    Who may submit referrals and pre-authorization requests

    Referrals and pre-authorization requests are accepted from both PCPs and specialist providers, though tests are ideally ordered by a medical professional with genetics training.

    • If you have questions or need medical necessity criteria, contact Medical Management at (888) 327-0671.

    Definitions

    Ordering practitioner with genetics training
    DefinitionA medical professional with formal training in genetics who orders genetic testing and ensures face-to-face genetic counseling accompanies testing.
    Examples of appropriate professionalsMedical geneticist; developmental‑behavioral pediatrician; condition‑specific subspecialist with genetics training; neonatologist in the NICU.
    Ordering responsibilityThe ordering practitioner must provide required pre-authorization information (11 specific questions) including confirmation that the test was ordered by a practitioner with genetics training.
    Counseling requirementSuch practitioners must ensure that face‑to‑face genetic counseling by appropriately trained professional(s) will accompany testing.
    Related verificationPre-authorization requests must explicitly state whether the ordering practitioner has genetics training (question 11 of the required 11 questions).

    Eligibility Requirements

    Pre-authorization documentation should state whether a pathogenic variant has been identified in an affected family member. This corresponds to question 9 in the required 11-item checklist and is used to determine the relevance of targeted testing and the probability that testing will yield actionable results.

    Pre-authorization requests must indicate whether this is the first time the test is being performed on the patient (question 10) and whether a pathogenic variant has been identified in an affected family member (question 9). These items help reviewers understand prior testing history and the potential diagnostic yield of repeat versus targeted testing.

    Background

    Genetic testing may be either a targeted single-gene test or a multi-gene panel, and results can affect diagnosis and medical management. McLaren Medical Management evaluates requests using external medical necessity resources (for example, Hayes and Apollo) and the referenced framework of 11 questions to determine appropriateness and clinical utility.

    Not Covered

    The policy does not name specific genetic tests that are categorically not covered. Instead, all genetic tests require pre-authorization, and coverage is determined based on the information provided in the pre-authorization request and the medical necessity evaluation.